Hypereosinophilic Syndrome in the Tyrosine Kinase Inhibitor Era
Gespeichert in:
| Veröffentlicht in: | Internal Medicine 2015, Vol.54(6), pp.551-552 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 552 |
|---|---|
| container_issue | 6 |
| container_start_page | 551 |
| container_title | Internal Medicine |
| container_volume | 54 |
| creator | Takahashi, Naoto |
| description | |
| doi_str_mv | 10.2169/internalmedicine.54.3258 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1665122752</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1665122752</sourcerecordid><originalsourceid>FETCH-LOGICAL-c504t-4861b7d1cd843c0f2f72d74c61921030fdd848d6ddbffbaf91c4c5c6d9060e303</originalsourceid><addsrcrecordid>eNptkD9PwzAQxS0EoqXwFVBGlhT_TzIhVBWKqGCgzJZjX4irxCl2OvTbk6qlA2K5G97v3js9hBKCp5TI4t75HoLXTQvWGedhKviUUZGfoTFhvEgzysQ5GuOC5CkdxghdxbjGmOVZQS_RiIosl5zTMXpY7DYQoIvOd5vaNc4kHztvQ9dC4nzS15CsdmEvQ_LqvI6QvPjala7vQjIP-hpdVLqJcHPcE_T5NF_NFuny_fll9rhMjcC8T3kuSZlZYmzOmcEVrTJqM24kKSjBDFd2EHIrrS2rqtRVQQw3wkhbYImBYTZBdwffTei-txB71bpooGm0h24bFZFSEEozQQc0P6Bm-DsGqNQmuFaHnSJY7etTf-tTgqt9fcPp7TFlWw7i6fC3rwF4OwDr2OsvOAE69M408K-z3I9jwgk0tQ4KPPsB7qiOXA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1665122752</pqid></control><display><type>article</type><title>Hypereosinophilic Syndrome in the Tyrosine Kinase Inhibitor Era</title><source>J-STAGE Free</source><source>MEDLINE</source><creator>Takahashi, Naoto</creator><creatorcontrib>Takahashi, Naoto</creatorcontrib><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.54.3258</identifier><identifier>PMID: 25786442</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject><![CDATA[Antineoplastic Agents - administration & dosage ; Benzamides - administration & dosage ; Eosinophilia - drug therapy ; Humans ; hypereosinophilic syndrome ; Leukemia, Myeloid - diagnosis ; Leukemia, Myeloid - drug therapy ; Male ; mRNA Cleavage and Polyadenylation Factors - isolation & purification ; Oncogene Proteins, Fusion - isolation & purification ; Piperazines - administration & dosage ; platelet-derived growth factor receptor alpha ; Pyrimidines - administration & dosage ; Receptor, Platelet-Derived Growth Factor alpha - isolation & purification ; tyrosine kinase inhibitor]]></subject><ispartof>Internal Medicine, 2015, Vol.54(6), pp.551-552</ispartof><rights>2015 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c504t-4861b7d1cd843c0f2f72d74c61921030fdd848d6ddbffbaf91c4c5c6d9060e303</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,1877,4010,27900,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25786442$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Takahashi, Naoto</creatorcontrib><title>Hypereosinophilic Syndrome in the Tyrosine Kinase Inhibitor Era</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><subject>Antineoplastic Agents - administration & dosage</subject><subject>Benzamides - administration & dosage</subject><subject>Eosinophilia - drug therapy</subject><subject>Humans</subject><subject>hypereosinophilic syndrome</subject><subject>Leukemia, Myeloid - diagnosis</subject><subject>Leukemia, Myeloid - drug therapy</subject><subject>Male</subject><subject>mRNA Cleavage and Polyadenylation Factors - isolation & purification</subject><subject>Oncogene Proteins, Fusion - isolation & purification</subject><subject>Piperazines - administration & dosage</subject><subject>platelet-derived growth factor receptor alpha</subject><subject>Pyrimidines - administration & dosage</subject><subject>Receptor, Platelet-Derived Growth Factor alpha - isolation & purification</subject><subject>tyrosine kinase inhibitor</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkD9PwzAQxS0EoqXwFVBGlhT_TzIhVBWKqGCgzJZjX4irxCl2OvTbk6qlA2K5G97v3js9hBKCp5TI4t75HoLXTQvWGedhKviUUZGfoTFhvEgzysQ5GuOC5CkdxghdxbjGmOVZQS_RiIosl5zTMXpY7DYQoIvOd5vaNc4kHztvQ9dC4nzS15CsdmEvQ_LqvI6QvPjala7vQjIP-hpdVLqJcHPcE_T5NF_NFuny_fll9rhMjcC8T3kuSZlZYmzOmcEVrTJqM24kKSjBDFd2EHIrrS2rqtRVQQw3wkhbYImBYTZBdwffTei-txB71bpooGm0h24bFZFSEEozQQc0P6Bm-DsGqNQmuFaHnSJY7etTf-tTgqt9fcPp7TFlWw7i6fC3rwF4OwDr2OsvOAE69M408K-z3I9jwgk0tQ4KPPsB7qiOXA</recordid><startdate>2015</startdate><enddate>2015</enddate><creator>Takahashi, Naoto</creator><general>The Japanese Society of Internal Medicine</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2015</creationdate><title>Hypereosinophilic Syndrome in the Tyrosine Kinase Inhibitor Era</title><author>Takahashi, Naoto</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c504t-4861b7d1cd843c0f2f72d74c61921030fdd848d6ddbffbaf91c4c5c6d9060e303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Antineoplastic Agents - administration & dosage</topic><topic>Benzamides - administration & dosage</topic><topic>Eosinophilia - drug therapy</topic><topic>Humans</topic><topic>hypereosinophilic syndrome</topic><topic>Leukemia, Myeloid - diagnosis</topic><topic>Leukemia, Myeloid - drug therapy</topic><topic>Male</topic><topic>mRNA Cleavage and Polyadenylation Factors - isolation & purification</topic><topic>Oncogene Proteins, Fusion - isolation & purification</topic><topic>Piperazines - administration & dosage</topic><topic>platelet-derived growth factor receptor alpha</topic><topic>Pyrimidines - administration & dosage</topic><topic>Receptor, Platelet-Derived Growth Factor alpha - isolation & purification</topic><topic>tyrosine kinase inhibitor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takahashi, Naoto</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takahashi, Naoto</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hypereosinophilic Syndrome in the Tyrosine Kinase Inhibitor Era</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2015</date><risdate>2015</risdate><volume>54</volume><issue>6</issue><spage>551</spage><epage>552</epage><pages>551-552</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>25786442</pmid><doi>10.2169/internalmedicine.54.3258</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0918-2918 |
| ispartof | Internal Medicine, 2015, Vol.54(6), pp.551-552 |
| issn | 0918-2918 1349-7235 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1665122752 |
| source | J-STAGE Free; MEDLINE |
| subjects | Antineoplastic Agents - administration & dosage Benzamides - administration & dosage Eosinophilia - drug therapy Humans hypereosinophilic syndrome Leukemia, Myeloid - diagnosis Leukemia, Myeloid - drug therapy Male mRNA Cleavage and Polyadenylation Factors - isolation & purification Oncogene Proteins, Fusion - isolation & purification Piperazines - administration & dosage platelet-derived growth factor receptor alpha Pyrimidines - administration & dosage Receptor, Platelet-Derived Growth Factor alpha - isolation & purification tyrosine kinase inhibitor |
| title | Hypereosinophilic Syndrome in the Tyrosine Kinase Inhibitor Era |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T23%3A13%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hypereosinophilic%20Syndrome%20in%20the%20Tyrosine%20Kinase%20Inhibitor%20Era&rft.jtitle=Internal%20Medicine&rft.au=Takahashi,%20Naoto&rft.date=2015&rft.volume=54&rft.issue=6&rft.spage=551&rft.epage=552&rft.pages=551-552&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.54.3258&rft_dat=%3Cproquest_cross%3E1665122752%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1665122752&rft_id=info:pmid/25786442&rfr_iscdi=true |